Search clinical trials for: Ipilimumab Injection [Yervoy]
Total 10461 results
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Bristol-Myers SquibbRecruitingMesotheliomaUnited States
-
Sheba Medical CenterTerminatedA Combination of Adoptive T Cell Therapy and Ipilimumab Could Increase the Proportion of CR Patients, and Durability of ResponseIsrael
-
Sheba Medical CenterBristol-Myers Squibb; Checkmate PharmaceuticalsCompletedLiver Metastases | Colorectal Neoplasms MalignantIsrael
-
Herlev and Gentofte HospitalBristol-Myers SquibbRecruitingProstate Cancer Metastatic | Metastatic Castration-resistant Prostate Cancer | Castrate Resistant Prostate Cancer | Prostate Cancer Stage IVDenmark
-
GERCOR - Multidisciplinary Oncology Cooperative...Bristol-Myers SquibbRecruitingLocalized Oesogastric Adenocarcimona | MSI and or dMMRFrance
-
Idera Pharmaceuticals, Inc.Bristol-Myers SquibbTerminatedMetastatic MelanomaUnited States, Canada, Spain, United Kingdom, France, Australia, Germany, Italy, Netherlands, Sweden, Czechia
-
Hospital Israelita Albert EinsteinBristol-Myers Squibb; BravaRecruiting
-
Takara Bio Inc.TheradexCompletedMalignant MelanomaUnited States
-
Inge Marie SvaneRecruiting
-
MacroGenicsCompletedMelanoma | Non Small Cell Lung CancerUnited States
-
Ontario Clinical Oncology Group (OCOG)Bristol-Myers SquibbActive, not recruitingMetastatic Renal Cell CarcinomaCanada, Australia
-
Bristol-Myers SquibbCompletedCarcinoma, Renal CellUnited States, Italy, Brazil, Argentina, Australia, Austria, Belgium, Canada, Chile, China, Colombia, Czechia, France, Germany, Japan, Mexico, Netherlands, Poland, Romania, Russian Federation, Singapore, Spain, Switzerland, Turkey, United...
-
Prostate Oncology Specialists, Inc.CompletedProstate Cancer | Castrate Resistant Prostate CancerUnited States
-
Bristol-Myers SquibbCompletedLung CancerItaly, United States, France, Russian Federation, Spain, Argentina, Belgium, Brazil, Canada, Chile, Czechia, Germany, Greece, Hungary, Mexico, Netherlands, Poland, Romania, Switzerland, Turkey, United Kingdom
-
Italian Network for Tumor BiotherapyBristol-Myers SquibbCompletedMetastatic Malignant MelanomaItaly
-
Providence Health & ServicesBristol-Myers SquibbActive, not recruitingSquamous Cell Carcinoma of the Head and NeckUnited States
-
AIO-Studien-gGmbHBristol-Myers SquibbActive, not recruitingTransitional Cell Carcinoma | Metastatic Cancer | Advanced CancerGermany, Austria
-
Universitair Ziekenhuis BrusselCompletedStage IV Skin Melanoma | Stage IIIC Skin MelanomaBelgium
-
Diwakar DavarBristol-Myers SquibbCompleted
-
GERCOR - Multidisciplinary Oncology Cooperative...Bristol-Myers SquibbRecruitingColorectal Cancer Metastatic | MSI-H Colorectal CancerFrance
-
Italian Network for Tumor Biotherapy FoundationBristol-Myers SquibbUnknown
-
Grupo Español Multidisciplinar de MelanomaBristol-Myers SquibbCompleted
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingBladder Cancer | Urothelial CarcinomaNetherlands
-
Xencor, Inc.ICON plcActive, not recruitingRenal Cell Carcinoma | Nasopharyngeal Carcinoma | Small Cell Lung Cancer | Hepatocellular Carcinoma | Advanced Solid Tumors | Non-small Cell Lung Carcinoma | Squamous Cell Carcinoma of the Head and Neck | Cervical Carcinoma | Endometrial Carcinoma | Urothelial Carcinoma | Colorectal Carcinoma | Pancreatic Carcinoma and other conditionsUnited States
-
Italian Network for Tumor Biotherapy FoundationAstex Pharmaceuticals, Inc.Unknown
-
Bristol-Myers SquibbActive, not recruitingRenal Cell CarcinomaFrance, Spain, Chile, United States, Argentina, Austria, Czechia, Greece, Italy, Mexico, Poland, Portugal, Romania, Russian Federation
-
Parker Institute for Cancer ImmunotherapyBristol-Myers SquibbCompleted
-
AIO-Studien-gGmbHBristol-Myers SquibbCompletedCarcinoma, Renal Cell | Clear-cell Metastatic Renal Cell CarcinomaSpain, France, Italy, Germany, United Kingdom, Belgium, Czechia, Austria
-
Swiss Group for Clinical Cancer ResearchActive, not recruitingRenal Cell CarcinomaSwitzerland
-
Universita di VeronaNot yet recruitingHIV | HBV | Long COVID | NSCLC Stage IV | HCVItaly
-
Universitair Ziekenhuis BrusselRecruitingSolid Tumor | Non Small Cell Lung CancerBelgium
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingMalignant Melanoma Stage IIIUnited States, Netherlands, Australia
-
The Netherlands Cancer InstituteCompletedHead and Neck Neoplasms | ImmunotherapyNetherlands
-
Bristol-Myers SquibbCompletedMelanomaBelgium, Brazil, United States, Canada, Spain, Greece, France, United Kingdom, Australia, Italy, Austria, Switzerland, Germany, Israel, Russian Federation, Romania, Czechia, Poland, New Zealand
-
CelgeneNYU Langone Health; Syneos Health; Celerion; ApoCell, Inc.CompletedMalignant MelanomaUnited States
-
Italian Network for Tumor Biotherapy FoundationBristol-Myers Squibb; Astex Pharmaceuticals, Inc.Not yet recruitingMelanoma | Non Small Cell Lung CancerItaly
-
University of Texas Southwestern Medical CenterCompletedKidney Cancer | Kidney Cancer Metastatic | Kidney Cancer, Stage IVUnited States
-
Bristol-Myers SquibbTerminatedCancer, HepatocellularChina, United States, Germany, Australia, Italy, Austria, Belgium, Czechia, France, Hong Kong, Japan, Korea, Republic of, Poland, Puerto Rico, Russian Federation, Singapore, Spain, Taiwan, Canada
-
Goethe UniversityActive, not recruitingMetastatic Renal Cell CarcinomaSpain, Netherlands, United Kingdom, France, Germany, Belgium, Czechia
-
Gritstone bio, Inc.Bristol-Myers SquibbCompletedColorectal Cancer | Non Small Cell Lung Cancer | Gastroesophageal Adenocarcinoma | Urothelial CarcinomaUnited States, Australia
-
The Netherlands Cancer InstituteBristol-Myers SquibbRecruitingNeoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer (NESCIO)Renal Cell CarcinomaUnited Kingdom, Netherlands
-
David Minor, MDUniversity of Chicago; Jefferson Medical College of Thomas Jefferson University and other collaboratorsActive, not recruitingUveal Melanoma | Hepatic MetastasesUnited States
-
Rabih SaidAgenus Inc.Withdrawn
-
Bristol-Myers SquibbCompletedProstate CancerAustralia, United States, Chile, Spain, France, Italy, United Kingdom, Germany, Netherlands
-
Bristol-Myers SquibbJSS Medical Research Inc.Completed
-
Prof. Dr. med. Dirk SchadendorfCompletedOcular MelanomaGermany
-
Patrick Wen, MDBristol-Myers SquibbActive, not recruitingGlioblastoma | Glioblastoma Multiforme | GBM | Grade IV AstrocytomaUnited States
-
Bristol-Myers SquibbCompletedPlatinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-lineUnited States
-
Bristol-Myers SquibbCompleted